MORGAN STANLEY PLC/CALL/AMGEN/520/0.1/19.09.25 | Market Closed - Börse Stuttgart 15:20:00 2024-06-07 EDT | ||
| 0.41 EUR | -2.38% |
|
| Current month | -6.82% | ||
| 1 month | +2.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-07 | 0.41 | -2.38% |
| 24-06-06 | 0.42 | -6.67% |
| 24-06-05 | 0.45 | +4.65% |
| 24-06-04 | 0.43 | 0.00% |
| 24-06-03 | 0.43 | -2.27% |
Delayed Quote Börse Stuttgart
Last update June 07, 2024 at 03:20 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME8619 |
| ISIN | DE000ME86193 |
| Date issued | 2024-02-05 |
| Strike | 520 $ |
| Maturity | 2025-09-19 (467 Days) |
| Parity | 10 : 1 |
| Emission price | 0.31 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.57 € |
|---|---|
| Lowest since issue | 0.25 € |
| Spread | 0.03 € |
| Spread % | 6.82% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305
USD
Average target price
316.3
USD
Spread / Average Target
+3.69%
- Stock Market
- Warrants
- Warrant
